sur ABIONYX (EPA:ABNX)
ABIONYX Pharma Secures Approval for All General Meeting Resolutions
ABIONYX Pharma, a biotech firm known for its innovative approaches to therapy development, has successfully garnered approval for all resolutions put forth at its Combined General Meeting. The meeting took place on June 27th, 2025, with shareholders participating in various capacities, including in-person, by representation, or via postal voting. These approvals reflect strong shareholder backing for the company's strategic objectives.
The company expressed gratitude towards its shareholders for their continued support. Detailed minutes and voting outcomes from the meeting are accessible in the Shareholder Meeting section of ABIONYX Pharma's website.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIONYX